https://www.globenewswire.com/de/news-release/2024/07/30/2921135/0/en/kabafusion-selected-by-gc-biopharma-usa-inc-as-a-limited-distribution-partner-for-partner-of-alyglo-for-adults-with-primary-humoral-immunodeficiency-pi.html
KabaFusion Selected by GC Biopharma USA, Inc. as a Limited
CERRITOS, Calif. and LEXINGTON, Mass., July 30, 2024 (GLOBE NEWSWIRE) -- KabaFusion, a nationally recognized leader in home infusion, has been selected...
selected bygc biopharmakabafusionusainc
https://www.globenewswire.com/news-release/2024/07/30/2921135/0/en/kabafusion-selected-by-gc-biopharma-usa-inc-as-a-limited-distribution-partner-for-partner-of-alyglo-for-adults-with-primary-humoral-immunodeficiency-pi.html
KabaFusion Selected by GC Biopharma USA, Inc. as a Limited
CERRITOS, Calif. and LEXINGTON, Mass., July 30, 2024 (GLOBE NEWSWIRE) -- KabaFusion, a nationally recognized leader in home infusion, has been selected...
selected bygc biopharmakabafusionusainc
https://www.globenewswire.com/fr/news-release/2024/07/30/2921135/0/en/kabafusion-selected-by-gc-biopharma-usa-inc-as-a-limited-distribution-partner-for-partner-of-alyglo-for-adults-with-primary-humoral-immunodeficiency-pi.html
KabaFusion Selected by GC Biopharma USA, Inc. as a Limited
CERRITOS, Calif. and LEXINGTON, Mass., July 30, 2024 (GLOBE NEWSWIRE) -- KabaFusion, a nationally recognized leader in home infusion, has been selected...
selected bygc biopharmakabafusionusainc
https://simplywall.st/stocks/kr/pharmaceuticals-biotech/kose-a006280/gc-biopharma-shares/news/gc-biopharmas-krx006280-earnings-may-just-be-the-starting-po
GC Biopharma's (KRX:006280) Earnings May Just Be The Starting Point - Simply Wall St News
GC Biopharma Corp. ( KRX:006280 ) just reported healthy earnings but the stock price didn't move much. Investors are...
https://www.biospace.com/u-s-fda-accepts-biologics-license-application-for-gc-biopharma-s-gc5107b-immune-globulin-intravenous-human-10-percent-liquid
U.S. FDA Accepts Biologics License Application for GC Biopharma's GC5107B (Immune Globulin...
Jul 31, 2023 - GC Biopharma, a global biopharmaceutical company dedicated to specialty plasma-derived therapeutics, announced that the U.S. Food and Drug Administration has...